Er Therapeutics Stock Forecast - Day Typical Price
| PNGM Stock | USD 0.0001 0.00 0.00% |
PNGM Stock Forecast is based on your current time horizon. Although Er Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Er Therapeutics' systematic risk associated with finding meaningful patterns of Er Therapeutics fundamentals over time.
PNGM |
| Previous Day Typical Price | Day Typical Price | Trend |
| 1.0E-4 | 1.0E-4 |
| Check Er Therapeutics Volatility | Backtest Er Therapeutics | Information Ratio |
Er Therapeutics Trading Date Momentum
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Er Therapeutics to competition |
Other Forecasting Options for Er Therapeutics
For every potential investor in PNGM, whether a beginner or expert, Er Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PNGM Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PNGM. Basic forecasting techniques help filter out the noise by identifying Er Therapeutics' price trends.Er Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Er Therapeutics stock to make a market-neutral strategy. Peer analysis of Er Therapeutics could also be used in its relative valuation, which is a method of valuing Er Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Er Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Er Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Er Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Er Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Er Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Er Therapeutics shares will generate the highest return on investment. By undertsting and applying Er Therapeutics stock market strength indicators, traders can identify Er Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Er Therapeutics to cross-verify your projections. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.95) |
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.